Merck slashed its profit forecast as acquisition costs piled up, but it beat on revenue

Merck reduced its adjusted earnings forecast to $2.66 to $2.76 per share from a previous range of $5.04 to $5.16. Despite the profit cut, the company exceeded revenue expectations.